Cargando…

酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342884/
https://www.ncbi.nlm.nih.gov/pubmed/31495143
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.08.017
_version_ 1783555619919233024
collection PubMed
description
format Online
Article
Text
id pubmed-7342884
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73428842020-07-16 酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习 Zhonghua Xue Ye Xue Za Zhi 经验交流 Editorial office of Chinese Journal of Hematology 2019-08 /pmc/articles/PMC7342884/ /pubmed/31495143 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.08.017 Text en 2019年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 经验交流
酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
title 酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
title_full 酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
title_fullStr 酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
title_full_unstemmed 酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
title_short 酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
title_sort 酪氨酸激酶抑制剂治疗慢性髓性白血病继发ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
topic 经验交流
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342884/
https://www.ncbi.nlm.nih.gov/pubmed/31495143
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.08.017
work_keys_str_mv AT làoānsuānjīméiyìzhìjìzhìliáomànxìngsuǐxìngbáixuèbìngjìfāphyīnxìng8rǎnsètǐyìchánggǔsuǐzēngshēngyìchángzōnghézhēngyīlìbàogàobìngwénxiànfùxí
AT làoānsuānjīméiyìzhìjìzhìliáomànxìngsuǐxìngbáixuèbìngjìfāphyīnxìng8rǎnsètǐyìchánggǔsuǐzēngshēngyìchángzōnghézhēngyīlìbàogàobìngwénxiànfùxí
AT làoānsuānjīméiyìzhìjìzhìliáomànxìngsuǐxìngbáixuèbìngjìfāphyīnxìng8rǎnsètǐyìchánggǔsuǐzēngshēngyìchángzōnghézhēngyīlìbàogàobìngwénxiànfùxí
AT làoānsuānjīméiyìzhìjìzhìliáomànxìngsuǐxìngbáixuèbìngjìfāphyīnxìng8rǎnsètǐyìchánggǔsuǐzēngshēngyìchángzōnghézhēngyīlìbàogàobìngwénxiànfùxí
AT làoānsuānjīméiyìzhìjìzhìliáomànxìngsuǐxìngbáixuèbìngjìfāphyīnxìng8rǎnsètǐyìchánggǔsuǐzēngshēngyìchángzōnghézhēngyīlìbàogàobìngwénxiànfùxí
AT làoānsuānjīméiyìzhìjìzhìliáomànxìngsuǐxìngbáixuèbìngjìfāphyīnxìng8rǎnsètǐyìchánggǔsuǐzēngshēngyìchángzōnghézhēngyīlìbàogàobìngwénxiànfùxí